All Peptides
Browse our full catalog of research-grade peptides. All products are lab-tested with ≥99% purity.
Precision science, molecule by molecule
Controlled synthesis, HPLC/MS analysis of every batch and a −20 °C cold chain to your door. That's how every FormulaPep vial is born.
- HPLC purity 99%+
- External CoA per batch
- −20 °C cold chain
7 dosesReference-grade research compound. Studied in relation to incretin pathways (GLP-1, GIP) and metabolic regulation in animal models.

Reference-grade research compound. Studied in relation to cellular senescence markers, mitophagy and telomeric dynamics in preclinical models.
2 dosesReference-grade research peptide. Studied in preclinical models in relation to angiogenesis, fibroblast migration and tissue-repair processes.
2 dosesReference-grade research peptide. Studied in preclinical models in relation to angiogenesis, fibroblast migration and tissue-repair processes.
2 dosesReference-grade research peptide. Studied in preclinical models in relation to angiogenesis, fibroblast migration and tissue-repair processes.

Reference-grade research peptide. Studied in preclinical models in relation to angiogenesis, fibroblast migration and tissue-repair processes.

Reference-grade research peptide. Studied in preclinical models in relation to angiogenesis, fibroblast migration and tissue-repair processes.

Reference-grade research peptide. Studied in preclinical models in relation to angiogenesis, fibroblast migration and tissue-repair processes.
4 dosesReference-grade research compound. Studied in relation to incretin pathways (GLP-1, GIP) and metabolic regulation in animal models.
7 dosesReference-grade research compound. Studied in relation to incretin pathways (GLP-1, GIP) and metabolic regulation in animal models.
2 dosesReference-grade research compound. Studied in relation to incretin pathways (GLP-1, GIP) and metabolic regulation in animal models.
2 dosesReference-grade research compound. Studied in relation to the GH/IGF-1 axis and somatotropic signaling in preclinical models.
2 dosesReference-grade research compound. Studied in relation to the GH/IGF-1 axis and somatotropic signaling in preclinical models.

Reference-grade research compound. Studied in relation to the GH/IGF-1 axis and somatotropic signaling in preclinical models.
2 dosesReference-grade research compound. Studied in relation to the GH/IGF-1 axis and somatotropic signaling in preclinical models.
2 dosesReference-grade research compound. Studied in relation to the GH/IGF-1 axis and somatotropic signaling in preclinical models.

Reference-grade research compound. Studied in relation to the GH/IGF-1 axis and somatotropic signaling in preclinical models.
2 dosesReference-grade research compound. Studied in relation to the GH/IGF-1 axis and somatotropic signaling in preclinical models.

Reference-grade research compound. Studied in relation to the GH/IGF-1 axis and somatotropic signaling in preclinical models.
3 dosesReference-grade research compound. Studied in relation to the GH/IGF-1 axis and somatotropic signaling in preclinical models.

Reference-grade research compound. Studied in relation to the GH/IGF-1 axis and somatotropic signaling in preclinical models.

Reference-grade research compound. Studied in relation to the GH/IGF-1 axis and somatotropic signaling in preclinical models.
2 dosesReference-grade nootropic research peptide. Studied in preclinical models in relation to neuroplasticity, BDNF and neuropeptide pathways.
2 dosesReference-grade nootropic research peptide. Studied in preclinical models in relation to neuroplasticity, BDNF and neuropeptide pathways.
2 dosesReference-grade nootropic research peptide. Studied in preclinical models in relation to neuroplasticity, BDNF and neuropeptide pathways.

Reference-grade nootropic research peptide. Studied in preclinical models in relation to neuroplasticity, BDNF and neuropeptide pathways.

Reference-grade research peptide. Studied in relation to melanocortin-3/4 receptor activation in preclinical models.

Reference-grade research peptide. Studied in relation to melanocortin-3/4 receptor activation in preclinical models.
2 dosesReference-grade research peptide. Studied in relation to melanocortin-3/4 receptor activation in preclinical models.

Reference-grade research peptide. Studied in relation to melanocortin-3/4 receptor activation in preclinical models.
2 dosesReference-grade research peptide. Studied in relation to melanocortin-3/4 receptor activation in preclinical models.

Reference-grade research peptide. Studied in relation to melanocortin-3/4 receptor activation in preclinical models.

Reference-grade research compound. Studied in relation to cellular senescence markers, mitophagy and telomeric dynamics in preclinical models.
3 dosesReference-grade research compound. Studied in relation to cellular senescence markers, mitophagy and telomeric dynamics in preclinical models.
2 dosesReference-grade research compound. Studied in relation to cellular senescence markers, mitophagy and telomeric dynamics in preclinical models.

Reference-grade research compound. Studied in relation to cellular senescence markers, mitophagy and telomeric dynamics in preclinical models.

Reference-grade research compound. Studied in relation to cellular senescence markers, mitophagy and telomeric dynamics in preclinical models.

Reference-grade research blend or consumable for laboratory use.

Reference-grade research blend or consumable for laboratory use.

Reference-grade research blend or consumable for laboratory use.
2 dosesReference-grade research blend or consumable for laboratory use.



